secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0001641172-25-005876
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma furnishes corporate presentation with no material new disclosures
--------------------------------------------------------------------------------

- Filed an investor presentation on April 23, 2025 under Item 7.01 Regulation FD.
- Presentation content not provided; no specific data on pipeline, finances, or milestones.
- No material operational, financial, or strategic updates disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000164117225005876/0001641172-25-005876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000164117225005876/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-005876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer